Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRIW) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Biofrontera (BFRIW) over the last 4 years, with Q3 2025 value amounting to $1000.0.

  • Biofrontera's Non Operating Investment Income rose 15000.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1000.0, marking a year-over-year increase of 9987.48%. This contributed to the annual value of -$14000.0 for FY2024, which is 9981.13% up from last year.
  • Latest data reveals that Biofrontera reported Non Operating Investment Income of $1000.0 as of Q3 2025, which was up 15000.0% from $2000.0 recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Non Operating Investment Income ranged from a high of $1.7 million in Q4 2022 and a low of -$2.9 million during Q1 2023
  • For the 4-year period, Biofrontera's Non Operating Investment Income averaged around -$516909.1, with its median value being -$2000.0 (2024).
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first tumbled by 14499.14% in 2023, then soared by 15000.0% in 2025.
  • Biofrontera's Non Operating Investment Income (Quarter) stood at $1.7 million in 2022, then tumbled by 144.99% to -$786000.0 in 2023, then skyrocketed by 99.75% to -$2000.0 in 2024, then skyrocketed by 150.0% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q3 2025, $2000.0 for Q2 2025, and -$2000.0 during Q4 2024.